FLORATEK Trademark

Trademark Overview


On Wednesday, October 13, 2021, a trademark application was filed for FLORATEK with the United States Patent and Trademark Office. The USPTO has given the FLORATEK trademark a serial number of 79328409. The federal status of this trademark filing is REGISTERED as of Tuesday, June 6, 2023. This trademark is owned by Floratek Pharma SA. The FLORATEK trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations, namely a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; medicinal preparations for the treatment of infectious diseases and for use in oncology; therapeutic preparations for treating cardiovascular diseases; pharmaceutical and medicinal preparations and substances for the treatment of diabetes; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical and medicinal preparations, substances and compositions for the treatment and/or prevention of cancer; pharmaceutical and medicinal preparations and substances for the treatment of neurodegenerative disorders; pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; pharmaceutical and m...

Scientific research; pharmaceutical research; medical research services in the field of medicines; technical advice for third parties in the field of development of pharmaceutical products; product development for third parties in the field of pharmaceutical products; research and development of pharmaceuticals and medicinal preparations and substances for third parties; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of cancer; research and development of pharmaceuticals and medicinal preparations and substances for treating inflammation; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of neurodegenerative disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; re...
floratek

General Information


Serial Number79328409
Word MarkFLORATEK
Filing DateWednesday, October 13, 2021
Status700 - REGISTERED
Status DateTuesday, June 6, 2023
Registration Number7070613
Registration DateTuesday, June 6, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements


Goods and ServicesPharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations, namely a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; medicinal preparations for the treatment of infectious diseases and for use in oncology; therapeutic preparations for treating cardiovascular diseases; pharmaceutical and medicinal preparations and substances for the treatment of diabetes; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical and medicinal preparations, substances and compositions for the treatment and/or prevention of cancer; pharmaceutical and medicinal preparations and substances for the treatment of neurodegenerative disorders; pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis; pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases
Goods and ServicesScientific research; pharmaceutical research; medical research services in the field of medicines; technical advice for third parties in the field of development of pharmaceutical products; product development for third parties in the field of pharmaceutical products; research and development of pharmaceuticals and medicinal preparations and substances for third parties; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of cancer; research and development of pharmaceuticals and medicinal preparations and substances for treating inflammation; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of neurodegenerative disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis; research and development of pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 20, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFloratek Pharma SA
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressAubonne
CH

Party NameFloratek Pharma SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressAubonne
CH

Party NameFloratek Pharma SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressAubonne
CH

Trademark Events


Event DateEvent Description
Monday, December 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 16, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 24, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, July 19, 2022ASSIGNED TO EXAMINER
Wednesday, July 20, 2022NON-FINAL ACTION WRITTEN
Thursday, July 21, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 11, 2022REFUSAL PROCESSED BY MPU
Thursday, August 11, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 29, 2022REFUSAL PROCESSED BY IB
Sunday, February 5, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Sunday, February 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 1, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 1, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023NOTIFICATION PROCESSED BY IB
Wednesday, May 17, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, June 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 17, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 6, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, September 7, 2023FINAL DISPOSITION PROCESSED
Thursday, September 7, 2023FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, June 6, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 6, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, October 3, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 6, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 1, 2024NEW REPRESENTATIVE AT IB RECEIVED